Rebate stacking optimizer
Find your cheapest legitimate GLP-1 path in 30 seconds
Best path
Commercial insurance + PA + Novo savings card
$25/month
Annual savings vs retail (~$1,349/mo): $15,888/year
Requirements
- · Commercial insurance that covers Wegovy
- · Prior authorization approved
- · Activate Novo Nordisk savings card (free at wegovy.com)
Best path if available. Card lowers copay typically to $0-25/mo up to an annual benefit cap set in the card terms. Beware copay accumulator plans which nullify the card's contribution toward your deductible.
All paths for your situation
Commercial insurance + PA + Novo savings card
$25/mo
Best path if available. Card lowers copay typically to $0-25/mo up to an annual benefit cap set in the card terms. Beware copay accumulator plans which nullify the card's contribution toward your deductible.
Editorial estimates based on publicly listed 2026 pricing and manufacturer program rules. Programs change; verify eligibility and pricing on the manufacturer site before assuming. Discount cards (GoodRx) and manufacturer savings cards are mutually exclusive at the pharmacy counter — apply one, not both.
The stacking rules you need to know
- Manufacturer savings cards + GoodRx don't stack. At the pharmacy counter, the cashier applies one OR the other — not both. Always run the manufacturer card first; GoodRx as backup only if no card available.
- Copay accumulators silently break savings cards. Many 2026 commercial plans don't count manufacturer card payments toward your deductible. You still get the monthly discount but you'll hit your deductible months later than expected.
- Savings cards exclude government insurance; NovoCare self-pay does not. Medicare, Medicaid, and TRICARE patients can't use manufacturer savings cards, but they can pay NovoCare's Wegovy self-pay price, which runs outside insurance and doesn't count toward a deductible. On Medicare, check the GLP-1 Bridge first: $50/month for Wegovy, Zepbound KwikPen, and Foundayo from July 1, 2026 to December 31, 2027.
- Foundayo (orforglipron) self-pay via LillyDirect is priced by dose. $149/mo for 0.8 mg and 2.5 mg, $199 for 5.5 mg, $299 for 9 mg and higher. The 2.5 mg and 5.5 mg prices are introductory through December 31, 2026.
- Vial vs pen pricing differs. LillyDirect Zepbound vials ($299-449/mo when refilled within 45 days) are significantly cheaper than pens. Trade-off: you draw your own dose with a syringe.